Ftse Mib
38.211,91
0,62%
DAX
22.559,77
0,34%
S&P 500
6.114,63
-0,01%
NASDAQ
20.026,77
0,41%
Bitcoin
96.144,09
0,01%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Voyager Therapeutics Inc (VYGR) Voyager Therapeutics Inc (VYGR) Notizie

Voyager Therapeutics Inc

VYGR
4,24
-0,14 (-3,20%)
15 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
12/2/202522:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202522:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202522:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/2/202521:44EDGAR2Form 144 - Report of proposed sale of securities
11/2/202521:40EDGAR2Form 144 - Report of proposed sale of securities
11/2/202521:36EDGAR2Form 144 - Report of proposed sale of securities
11/2/202513:07EDGAR2Form 8-K - Current report
11/2/202513:00GLOBEVoyager Provides Update on SOD1 ALS Gene Therapy Program
06/2/202513:00GLOBEVoyager to Present at Oppenheimer 25th Annual Healthcare..
15/1/202522:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/1/202522:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/1/202521:17EDGAR2Form 144 - Report of proposed sale of securities
14/1/202521:14EDGAR2Form 144 - Report of proposed sale of securities
26/12/202422:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202417:31EDGAR2Form 144 - Report of proposed sale of securities
20/11/202413:00GLOBEVoyager Selects Tau Silencing Gene Therapy Development..
12/11/202422:01GLOBEVoyager Reports Third Quarter 2024 Financial and Operating..
12/11/202422:00EDGAR2Form 8-K - Current report
06/11/202413:00GLOBEVoyager Therapeutics to Present at Multiple Upcoming..
05/11/202413:00GLOBEVoyager Therapeutics Announces Third Quarter 2024 Conference..
03/10/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202422:26EDGAR2Form 144 - Report of proposed sale of securities
02/10/202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/9/202413:00GLOBEVoyager Advances Collaboration with Neurocrine; Third Gene..
05/9/202414:06EDGAR2Form 8-K - Current report
05/9/202414:00GLOBEVoyager Enters into License for Next-Generation Capsid,..
29/8/202422:01GLOBEVoyager Therapeutics Announces Inducement Grants Under..
29/8/202413:00GLOBEVoyager Therapeutics to Present at Multiple Upcoming..
07/8/202413:00GLOBEVoyager Therapeutics to Present at Canaccord Genuity 44th..
06/8/202422:11EDGAR2Form S-8 - Securities to be offered to employees in employee..
06/8/202422:01GLOBEVoyager Therapeutics Reports Second Quarter 2024 Financial..
06/8/202422:00EDGAR2Form 8-K - Current report
30/7/202413:00GLOBEVoyager Therapeutics Announces Second Quarter 2024..
23/7/202422:01GLOBEVoyager Therapeutics Announces Inducement Grants Under..
09/7/202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/7/202422:10EDGAR2Form 3 - Initial statement of beneficial ownership of..
09/7/202422:01GLOBEVoyager Therapeutics Announces Inducement Grants Under..
13/6/202422:01GLOBEVoyager Therapeutics to Present at Multiple Virtual Investor..
13/6/202413:06EDGAR2Form 8-K - Current report
13/6/202413:00GLOBEVoyager Therapeutics Announces Appointment of Nathan..
07/6/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:04EDGAR2Form 8-K - Current report
16/5/202413:05EDGAR2Form 8-K - Current report
16/5/202413:00GLOBEVoyager Therapeutics Announces First Participants Dosed in..
13/5/202422:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/5/202422:01GLOBEVoyager Therapeutics Reports First Quarter 2024 Financial..
Apertura: 4,38 Min: 4,20 Max: 4,5999
Chiusura: 4,38

La tua Cronologia

NASDAQ
VYGR
Voyager Therapeutics
BIT
P1TJX4
BNP Paribas Issuance
AMEX
XLE
Energy Select Sector SPDR
BIT
P1TK49
BNP Paribas Issuance
EU
PHR
PHarol SGPS
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci